Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Phase II Trial of XL184 Cabozantinib an Oral Small-Molecule Inhibitor of Multiple Kinases, in Children and Young Adults with Refractory Sarcomas, Wilms Tumor, and Other Rare Tumors
Study Type: Treatment
Phase: II
NCTID: NCT02867592
Principal Investigator:
Kevin Ginn
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant AZD9833, a Next-Generation, Oral Selective Estrogen Receptor Degrader Versus Standard Endocrine Therapy Aromatase Inhibitor or Tamoxifen as Adjuvant Treatment for Patients with ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease
ARACOG: A Randomized Phase II Study of Androgen Receptor Directed Therapy on COGnitive Function in Patients Treated with Darolutamide or Enzalutamide
Study Type: Treatment
Phase: II
NCTID: NCT04335682
Principal Investigator:
Elizabeth Wulff-Burchfield
A Phase I/IIa, Multicenter, Open-label Trial of TBio-6517, an Oncolytic Vaccinia Virus, Administered Alone and in Combination with Pembrolizumab, in Patients with Advanced Solid Tumors
Phase II Study in Patients With Resected, Stage II High Risk and Stage III Colorectal Cancer
Phase II Trial of Intravesical Gemcitabine and MK-3475 Pembrolizumab in the Treatment of Patients with BCGUnresponsive Non-Muscle Invasive Bladder Cancer
A Phase III, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA IT PET/CT in Staging of Men with Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy with Pelvic Lymph Node Dissection
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine DFMO
Study Type: Prevention
Phase: II
NCTID: NCT02679144
Principal Investigator:
Kevin Ginn